Paolo Martini

Paolo Martini

Company: Moderna Therapeutics

Job title: Chief Scientific Officer Rare Diseases

Seminars:

Live Presenter Q&A 10:20 am

Read more

day: Day One

An mRNA Therapeutic Approach to Targeting Inborn Errors of Metabolism 10:00 am

• An overview of the mRNA technology • Particular focus on modification of mRNA and lipid nano particles for delivery to be as suitable as possible for inborn errors of metabolism • Covering a couple of examples of how this works in animal models of disease, highlighting differences and complementarities with gene therapyRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.